Real-world Use of Elbasvir-Grazoprevir in Chronic HCV Real-world Use of Elbasvir-Grazoprevir in Chronic HCV

This retrospective analysis evaluated outcomes of hepatitis C patients treated with elbasvir-grazoprevir with or without ribavirin in clinical practice settings in the United States.Alimentary Pharmacology & Therapeutics

Source: Medscape Today Headlines - July 17, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news